BioCryst Pharma Market Sentiment

BioCryst Pharmaceuticals Inc

BCRXNASDAQ

Trade with Public

$8.14

-0.10-1.27%

마지막 업데이트: Nov 2, 4:41 PM

개요 뉴스 실적 전망 이벤트 목표가 재무심리지분 현황 비교 옵션 주식 보고서

실적: Q3 2026 실적이 내일 수 11월 4th에 개장 전 발표됩니다.

컨퍼런스 콜: 내일 8:30 오전에 컨퍼런스 콜이 예정되어 있습니다.

웹캐스트를 보려면 클릭하세요.

BioCryst Pharma Market Sentiment - Benzinga

BioCryst Pharma Market Sentiment

Market sentiment signals for BioCryst Pharma (BCRX): analyst consensus, short interest, options flow and insider activity.

Key Signals

Analyst Consensus▲ Buy

Short Interest▲ 10.5% short float

Options Flow— N/A

Insider Activity— N/A

Analyst Consensus

Buy

14 analysts

Options Flow (P/C)

—

Avg Consensus PT

$21

+154.4%

Highest Price Target

$32

+293.1%

HC Wainwright & Co.

Lowest Price Target

+10.6%

Barclays

Short Interest

10.5%

Declining — Bullish

Insider Activity (30d)

—

Short Interest — % of Float

Recent Analyst Actions

Date	Firm	Analyst & Accuracy	Upside / Downside	PT Change	Action	Rating
Sep 30, 2026	JP Morgan	Jessica Fye—	+59.7%	$12 → $13	Maintained	Neutral
Sep 10, 2026	RBC Capital	Brian Abrahams—	+35.1%	$13 → $11	Downgrade	Outperform→Sector Perform
Sep 8, 2026	Needham	Serge Belanger—	+96.6%	$16 → $16	Maintained	Buy
Aug 6, 2026	RBC Capital	Brian Abrahams—	+59.7%	$14 → $13	Maintained	Outperform
Aug 6, 2026	Wedbush	Laura Chico—	+145.7%	$21 → $20	Maintained	Outperform
Jul 13, 2026	JP Morgan	Jessica Fye—	+47.4%	$12	Reinstates	Neutral
Jul 7, 2026	RBC Capital	Brian Abrahams—	+72.0%	$13 → $14	Maintained	Outperform
Jun 30, 2026	HC Wainwright & Co.	Andrew S. Fein—	+293.1%	$32 → $32	Maintained	Buy
Jun 30, 2026	Cantor Fitzgerald	Steven Seedhouse—	+256.3%	$27 → $29	Maintained	Overweight
May 7, 2026	Citizens	Jonathan Wolleben—	+244.0%	$25 → $28	Maintained	Market Outperform
May 7, 2026	Wedbush	Laura Chico—	+158.0%	$22 → $21	Maintained	Outperform
May 6, 2026	Needham	Serge Belanger—	+96.6%	$18 → $16	Maintained	Buy
Jan 30, 2026	RBC Capital	Brian Abrahams—	+59.7%	$14 → $13	Maintained	Outperform
Dec 15, 2025	HC Wainwright & Co.	Andrew S. Fein—	+293.1%	$30 → $32	Maintained	Buy
Nov 5, 2025	Citizens	Jonathan Wolleben—	+207.1%	$27 → $25	Maintained	Market Outperform
Nov 4, 2025	Barclays	Gena Wang—	+10.6%	$11 → $9	Maintained	Equal-Weight
Nov 4, 2025	Needham	Serge Belanger—	+121.1%	$20 → $18	Maintained	Buy
Oct 15, 2025	TD Cowen	Stacy Ku—	+268.6%	$30	Reinstates	Buy
Oct 15, 2025	Cantor Fitzgerald	Steven Seedhouse—	+219.4%	$24 → $26	Maintained	Overweight
Oct 15, 2025	JMP Securities	Jonathan Wolleben—	+231.7%	$17 → $27	Maintained	Market Outperform
Oct 15, 2025	Needham	Serge Belanger—	+145.7%	$17 → $20	Maintained	Buy
Aug 4, 2025	Needham	Serge Belanger—	+108.8%	$17 → $17	Maintained	Buy
Jul 1, 2025	B of A Securities	Tazeen Ahmad—	+84.3%	$13 → $15	Maintained	Buy
Jun 30, 2025	RBC Capital	Brian Abrahams—	+59.7%	$13 → $13	Maintained	Outperform
Jun 30, 2025	Wedbush	Laura Chico—	+121.1%	$16 → $18	Maintained	Outperform